Stay updated on Daratumumab for AML/High-Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for AML/High-Risk MDS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s displayed revision/version has been bumped from v3.5.2 to v3.5.3, indicating a website/app release rather than an update to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:16.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:34.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:00:56.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page. No changes to study data or page navigation are indicated.
    Difference
    0.1%
    Check dated 2026-03-11T23:27:47.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the notice about lapse in government funding and the previous Revision: v3.4.1 entry.
    Difference
    0.5%
    Check dated 2026-02-11T10:28:30.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a page revision indicator (v3.4.1). Removed the previous revision indicator (v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-04T06:23:02.000Z thumbnail image

Stay in the know with updates to Daratumumab for AML/High-Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.